BPA Call 36C24923A0030-36C24924N0579
- Not listed
- The Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 9 awarded a Blanket Purchase Agreement (BPA) to Therakos, Inc., a foreign-owned for-profit corporation, to provide photopheresis light kits, UVADEX solution, and a photopheresis system. The BPA, which has a potential value of $32,704.56, was awarded on May 28, 2024 and has a completion date of May 31, 2024. Therakos is the prime contractor and there are no mentioned subcontractors....
- This federal contract award is for a Blanket Purchase Agreement (BPA) order between the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 9 and Therakos, Inc., a foreign-owned, for-profit corporation that specializes in photopheresis products and services. The $106,524.00 firm-fixed price contract is for the provision of the CELLEX Photopheresis System, UVADEX medication, and associated procedural kits and supplies used for extracorporeal photopheresis treatments at VA...
- The U.S. Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm fixed price purchase order to Therakos, Inc., a foreign-owned for-profit organization, to provide photopheresis kits. The $942,580.00 contract has a performance period ending on October 25, 2018 and was awarded on October 26, 2017. Therakos will deliver the photopheresis system kits, UVADEX medication, and associated supplies to VA medical facilities in Tennessee to support veteran healthcare programs....
- This federal contract award with a ceiling value of $106,524.00 was issued by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 9 to Therakos, Inc., a foreign-owned, for-profit corporation that specializes in photopheresis products and services. The award is for a Blanket Purchase Agreement (BPA) order to provide CELLEX Photopheresis System kits, UVADEX medication, and related supplies to support VA medical programs. Therakos also holds a $3.49 million BPA with the VA...
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded Therakos, Inc., a foreign-owned for-profit company, a $316,030.86 firm fixed-price purchase order contract to provide photopheresis procedural kits and supplies. The contract, which has no set-aside designation, supports veteran healthcare programs through the delivery of photopheresis system kits, UVADEX medication, and associated supplies to VA medical facilities. This contract award is part of Therakos' larger...
- This is a $62,139 firm-fixed price blanket purchase agreement (BPA) awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 9 to Therakos, Inc., a foreign-owned for-profit corporation. The BPA is for the delivery of Therakos' CELLEX Photopheresis System, UVADEX medication, and associated procedural kits and supplies to support extracorporeal photopheresis treatments at VA medical centers. Extracorporeal photopheresis is an FDA-approved apheresis procedure used to...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 9 to Therakos LLC, a foreign-owned for-profit corporation. The contract has a ceiling value of $111,708.00 and an ultimate completion date of September 22, 2025. The contract is for the provision of the CELLEX Photopheresis System procedural kits, UVADEX (methoxsalen) medication, and related medical equipment, which are used for extracorporeal...
- This is a federal contract award from the Department of Veterans Affairs (VA) Veterans Integrated Service Network 9 to Therakos, Inc., a foreign-owned, for-profit corporation that specializes in photopheresis medical technology and pharmaceutical products. The contract, valued at $192,885.00, is for the procurement of CELLEX Procedural Kits. The contract is a Firm Fixed Price Purchase Order with a period of performance ending on August 31, 2016. The contract does not have a set-aside...
- This firm-fixed price purchase order was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 9 to Therakos, Inc., a foreign-owned for-profit corporation, for the purchase of 18 photopheresis kits. The potential value of the award is $51,264.00 and the completion date is December 18, 2023. The contract is not associated with any socioeconomic set-aside programs. Therakos is a provider of photopheresis products and services to...
- This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 9 (VISN 9) of the Department of Veterans Affairs (VA) to Therakos, Inc., a foreign-owned, for-profit corporation, for the provision of photopheresis kits and supplies. The contract has a ceiling value of $304,542.00 and a period of performance ending on September 30, 2021. Therakos, Inc. is the prime contractor, and there are no major subcontractors mentioned. The contract supports the VA's healthcare...
- 36C24923A0030Blanket Purchase Agreement
- 36C24923A0030-36C24924N0579BPA Call
The U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 9 awarded a Blanket Purchase Agreement (BPA) to Therakos, Inc., a foreign-owned, for-profit corporation, for the provision of a photopheresis system and associated supplies. The award, valued at $106,524.00, is a firm-fixed price contract with a period of performance through August 5, 2024. Therakos, Inc. is the prime contractor and will be delivering the CELLEX Photopheresis System, UVADEX medication, and related procedural kits and supplies to support extracorporeal photopheresis treatments at VA medical facilities. This award is part of a larger $3.49 million BPA awarded to Therakos by the VA in September 2023, which covers the delivery of photopheresis equipment and pharmaceuticals through December 2024. Therakos also holds a $750,000 Federal Supply Schedule contract with the VA for hematology-related products. No set-aside designation was applied to this specific contract award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $106.5k | 7/26/24 |